The daily commitment of our employees and the constant search for the quality of processes and products, resulted in yet another great victory for the RPH Group.

On October 26, 2020, the approval of the Registration of the DMSA Kit was published in the Official Gazette (DOU), under the name RPHRENO, nº 1.7359.0004.001-1.

This fact reinforces the path of continuous improvement we are taking and motivates us to continue looking for more and more achievements. Grupo RPH, this achievement belongs to all of us!

SALE UNDER MEDICAL PRESCRIPTION. Product information, indications, dosages, contraindications, cautions and warnings, request the package leaflet by e-mail: